Lung (TRPM7)

From Magnesium
Revision as of 08:41, 27 January 2024 by Ossip Groth (talk | contribs) (Created page with "{{tp|p=35944979|t=2022. Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension.|pdf=|usr=}}{{35944979}} {{tp|p=33691194|t=2021. Substantial involvement of TRPM7 inhibition in the therapeutic effect of Ophiocordyceps sinensis on pulmonary hypertension.|pdf=|usr=}}{{33691194}} {{tp|p=38033335|t=2023. Mechanosensitive channels in lung disease.|pdf=|usr=}}{{38033335}} {{tp|p=29867539|t=2018. Revisiting the Role of TRP, Orai, and ASIC...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


35944979 PDF 2022. Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension.Template:35944979
33691194 PDF 2021. Substantial involvement of TRPM7 inhibition in the therapeutic effect of Ophiocordyceps sinensis on pulmonary hypertension.Template:33691194
38033335 PDF 2023. Mechanosensitive channels in lung disease.Template:38033335
29867539 PDF 2018. Revisiting the Role of TRP, Orai, and ASIC Channels in the Pulmonary Arterial Response to Hypoxia.Template:29867539
34349187 PDF 2021. Transcriptomic profile of cationic channels in human pulmonary arterial hypertension.Template:34349187

Retrieved from "http://mg.moremed.org:80/w/index.php?title=Lung_(TRPM7)&oldid=40"